This is an open-label observational single-group clinical trial to study the efficacy of a commercially available dietary supplement and its effect on common PMS and menstrual symptoms. It is hypothesized that the dietary supplement marketed as "Elix Cycle Balance" will improve subjective wellbeing in trial participants by alleviating common symptoms of PMS and menstrual symptoms, such as cramps, bloating, and mood swings. A total of 65 participants will be recruited for the trial following screening, with the expectation that at least 50 participants will complete the trial. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants. The total intervention study period will be 3 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
68
Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Citruslabs
Santa Monica, California, United States
Relief From Premenstrual Cramps [Time Frame: Baseline to 3 Months]
Survey-based assessment (0-5 scale) of changes in premenstrual cramps. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Menstrual Cramps During the Period [Time Frame: Baseline to 3 Months]
Survey-based assessment (0-5 scale) of changes in menstrual cramps. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Reduction in Usage of OTC NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms. [Time Frame: Baseline to 3 Months]
Survey-based assessment to assess the change in the number of over-the-counter NSAIDS used from baseline to 12 weeks. Participants were presented with the following options: 1 a day, 2 a day, 3 a day, 4+ a day. A lower score indicates a better outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Reduction in Mood Swings. [Time Frame: Baseline to Week 12]
Survey-based assessment (0-5 scale) of changes in mood swings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Feelings of Anxiety and Depression. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in anxiety and depression. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Acne Flare-ups. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in acne flare ups. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Headaches. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in headaches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Backaches. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in backaches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Body Aches. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in body aches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Bloating. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in bloating. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Gastrointestinal Issues. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in gastrointestinal issues. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Joint or Muscle Pain. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in joint or muscle pain. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Tiredness or Fatigue. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in tiredness and fatigue. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Reduction in Weight Gain Due to Fluid Retention. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in menstrual symptoms, fatigue, and mood swings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Relief From Breast Tenderness. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in breast tenderness. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
Changes in Appetite and Food Cravings. [Time Frame: Baseline to Month 3]
Survey-based assessment (0-5 scale) of changes in appetite and food cravings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.
Time frame: Baseline, Month 1, Month 2, Month 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.